| First choice | In men or women with AF and an additional stroke risk factor other than sex (i.e. CHA2DS2VASc score of 1 in men or 2 in women), OAC should be considered, based on limited clinical trial data dabigatran (150 mg twice daily is preferred) or apixaban may be considered |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.